TPST: Rega marang dodolan Tempest Tx
Tempest Therapeutics (TPST) price action depends on partner test outcomes and the cash burn rate. The market cap-to-revenue ratio visualizes these risks, where serves as the parameter's baseline value. While logistical disruptions hinder the procurement of biomaterials, the humanitarian status of medicine in the US ensures the stability of current clinical trials.
Rincian metrik lan analitis perusahaan Tempest Tx (TPST)
- kuotasi lan prakiraan analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal Tempest Therapeutics|TPST - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Tempest Therapeutics Corp|TPST - Gunggung utang perusahaan|Utang marang modal buku Tempest Tx|TPST - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Tempest Therapeutics|Rasio likuiditas perantara tempesttx.com
- data bathi bisnis lan rasio investasi:
TPST - Bathi resik|Penghasilan resik sing dikarepake Tempest Therapeutics|TPST - Pangali P/E|Rasio prakiraan rega marang bathi Tempest Therapeutics Inc|TPST - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Tempest Tx|TPST - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Tempest Therapeutics|TPST - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan tempesttx.com|TPST - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Tempest Therapeutics
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:tempesttx.com
For Tempest Therapeutics (TPST), which is advancing oncology developments while adhering to strict ESG emission filtration standards, the P/S ratio serves as an indicator of market confidence in future sales. This coefficient relates market capitalization to annual revenue, allowing for an assessment of the value of each unit of income. By analyzing the historical P/S trend, an investor can identify valuation anomalies relative to the company's operational successes. The stability of this metric confirms the balanced nature of the biopharmaceutical startup's financial model.
Karo sapa Tempest Therapeutics saingan
Kapitalisasi marang volume dodolan ONC|Multiplikator P/S HALO (Halozyme)|Revolution Medicines Inc (RVMD) - Rega marang dodolan|AAPG - Rasio rega marang pendapatan|CG Oncology Therapeutics (CGON) - Kapitalisasi marang pendapatan|UroGen Pharma Ltd. (URGN) - Rasio rega marang pendapatan|Rasio rega marang dodolan BCAX (bicara.com)|PSNL (Personalis) - Multiplikator P/S|Rega marang dodolan Erasca Inc ERAS|Rasio rega marang pendapatan Delcath (DCTH)|Koefisien rega marang pendapatan Y-mAbs Corp|Aura Biosciences, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan CADL (Candel Therapeutics Inc.)|ARAY: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics, Inc) - Kapitalisasi marang pendapatan|CTOR: Kapitalisasi marang volume dodolan|HURA (TuHURA Biosciences Inc.) - Multiplikator P/S|TARA: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FATE|WHWK - Rega marang dodolan|Rasio rega marang pendapatan TScan Therapeutics, Inc. TCRX|Rasio kapitalisasi pasar marang pendapatan CSBR|XBiotech USA - Multiplikator P/S|CVM - Multiplikator P/S|OS Therapies (OSTX) - Rasio rega marang pendapatan|Rasio rega marang dodolan RADX (radiopharmtheranostics.com)|ARTV (Artiva Biotherapeutics Inc.) - Multiplikator P/S|Rega marang dodolan Adlai Nortye Limited ANL|Kapitalisasi marang pendapatan VERU (Veru Inc.)|Multiplikator P/S xiliotx.com (XLO)|Renovaro - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan MURA (Mural Oncology PLC)|Kairos Pharma Inc - Multiplikator P/S|Koefisien rega marang pendapatan OnKure Therapeutics Inc OKUR|GDTC: Multiplikator P/S|Kapitalisasi marang pendapatan Curis|Rasio rega marang pendapatan Apollomics Inc.|Tharimmune Inc (THAR) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan ADVB (Advanced Biomed Inc)|Kapitalisasi marang volume dodolan GNPX|Rasio rega marang pendapatan Calidi Biotherapeutics, Inc. CLDI|SBFM (sunshinebiopharma.com) - Rasio rega marang dodolan|XBIO - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Salarius Pharmaceuticals Inc SLRX|PPBT (Purple Biotech Corp) - Kapitalisasi marang pendapatan|AONC: Kapitalisasi marang volume dodolan|BGNE (BeiGene, Ltd.) - Multiplikator P/S|Kapitalisasi marang pendapatan checkpointtx.com (CKPT)|Multiplikator P/S ELEV|Multiplikator P/S icadmed.com (ICAD)|Rasio rega marang pendapatan Ikena Oncology IKNA|NTBL: Rasio kapitalisasi marang pendapatan|Viracta - Multiplikator P/S|morphosys.com (MOR) - Kapitalisasi marang pendapatan|NAYA: Multiplikator P/S|Rega marang dodolan Ascentage Pharma Group International (AAPGV)
